2m 2m 2m 2m 2m 2m 2m
CARDIO DGNS HLD (CDIO)
NASDAQ
$2.19-$0.17 (-7.02%)
Price as of Jun 03, 2026 5:34 PM EDT- $5.6MMarket Cap
- -46.59%1-Year Change
- BiotechnologyIndustry
CARDIO DGNS HLD (CDIO)
$2.19-$0.17 (-7.02%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 14,825 -57.51% | 34,890 +104.45% | 17,065 +1,696.32% | 950 N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 14,825 -57.51% | 34,890 +104.45% | 17,065 +1,696.32% | 950 +104.55% | |
Sales and Marketing Expense | 766,888 +320.34% | 182,446 +15.10% | 158,514 +71.00% | 92,700 N/A | |
Research and Development Expense | -641,212 +2,101.59% | -29,125 -79.94% | -145,182 +258.93% | -40,448 N/A | |
Depreciation and Amortization Expense | 160,063 +40.68% | 113,777 +2,902.03% | 3,790 -76.31% | 16,000 N/A | |
Total Operating Expenses | 6.5M -22.64% | 8.4M +15.72% | 7.3M +59.57% | 4.5M +21,681.02% | |
Operating Profit | -6.5M -22.49% | -8.4M +15.51% | -7.2M +59.23% | -4.5M +3,029.93% | |
Interest Income | 712 -33.08% | 1,064 -0.37% | 1,068 N/A | N/A N/A | |
Interest Expense | -14,801 -20.60% | -18,640 -99.72% | -6.7M N/A | N/A N/A | |
Interest Income and Expense and Net | -14,089 -19.84% | -17,576 -99.74% | -6.7M N/A | 0 N/A | |
Total Nonoperating Income and Expense | -14,089 -19.84% | -17,576 -98.45% | -1.1M N/A | N/A N/A | |
Income before Taxes | -6.5M -22.49% | -8.4M +0.08% | -8.4M +79.72% | -4.7M +3,118.09% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -6.5M -22.49% | -8.4M +0.08% | -8.4M +79.72% | -4.7M +3,118.09% | |
Net Income from Continuing Operations Applicable to Common | -6.5M -22.49% | -8.4M +0.08% | -8.4M +79.72% | -4.7M +3,118.09% | |
Basic EPS and Net Income | -3.71 +1,096.77% | -0.31 -53.03% | -0.66 -56.29% | -1.51 N/A | |
Diluted EPS and Net Income | -3.71 +1,096.77% | -0.31 -53.03% | -0.66 -56.29% | -1.51 N/A | |
Basic Weighted Average Shares | 1.8M -93.49% | 26.9M +112.00% | 12.7M +310.83% | 3.1M +208.36% | |
Diluted Weighted Average Shares | 1.8M -93.49% | 26.9M +112.00% | 12.7M +310.83% | 3.1M +208.36% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.1M -34.71% | 7.8M +509.84% | 1.3M -68.83% | 4.1M +681.87% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 5.1M -34.71% | 7.8M +509.84% | 1.3M -68.83% | 4.1M +681.87% | |
Total Current Assets | 5.9M -32.65% | 8.8M +217.85% | 2.8M -53.01% | 5.9M +629.64% | |
Accumulated Depreciation | 277,630 +136.15% | 117,567 +3,002.03% | 3,790 N/A | N/A N/A | |
Property and Plant and Equipment and Net | 700,115 +4.05% | 672,861 +17.66% | 571,873 N/A | N/A N/A | |
Total Long-Term Assets | 700,115 +4.05% | 672,861 +17.66% | 571,873 N/A | N/A N/A | |
Total Assets | 7.8M -26.84% | 10.6M +137.89% | 4.5M -28.60% | 6.2M -90.50% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 604,839 -4.25% | 631,695 -24.90% | 841,142 -23.44% | 1.1M +782.99% | |
Total Long-Term Debt | N/A N/A | 419,475 0.00% | 419,475 0.00% | 419,475 +28.85% | |
Total Long-Term Liabilities | 188,222 -55.80% | 425,829 -35.78% | 663,099 N/A | N/A N/A | |
Total Liabilities | 793,061 -25.01% | 1.1M -29.70% | 1.5M -22.77% | 1.9M +1,465.30% | |
Retained Earnings | -29.3M +28.56% | -22.8M +58.35% | -14.4M +139.81% | -6.0M +4,036.75% | |
Total Stockholders Equity | 7.0M -27.04% | 9.6M +223.10% | 3.0M -31.23% | 4.3M +530.07% | |
Total Shares Outstanding | 1.8M -96.03% | 45.9M +123.68% | 20.5M +115.88% | 9.5M +485.52% | |
Cash Flow | |||||
Cash from Operating Activities | -5.7M +14.69% | -5.0M -11.97% | -5.7M +11.42% | -5.1M +1,591.67% | |
Capital Expenditures | 187,317 -12.78% | 214,765 -62.69% | 575,663 N/A | N/A N/A | |
Cash from Investing Activities | -419,310 +3.74% | -404,190 -49.11% | -794,291 +115.84% | -368,001 -99.43% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 3.4M -71.28% | 11.9M +228.74% | 3.6M -59.92% | 9.1M -86.23% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -43,737.46% +82.41% | -23,977.86% -43.50% | -42,440.43% -91.14% | -478,784.32% N/A | |
Return on Assets | -70.70% -36.42% | -111.20% -28.90% | -156.40% +1,108.96% | -12.94% N/A | |
Return on Equity | -78.62% -41.31% | -133.96% -41.95% | -230.77% +23.39% | -187.02% N/A | |
Revenue Growth | -57.51% -155.06% | 104.45% -93.84% | 1,696.32% N/A | N/A N/A | |
Current Ratio | 9.79 -29.66% | 13.92 +323.24% | 3.29 -38.62% | 5.36 N/A | |
Cash Ratio | 8.45 -31.81% | 12.39 +712.06% | 1.53 -59.28% | 3.75 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow